Canaccord Genuity on Lucid Diagnostics Inc (LUCD): 'we believe the stock does not reflect the company's long-term growth potential'
Tweet Send to a Friend
(Updated - September 5, 2025 5:32 AM EDT)
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $3.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Kyle Mikson reiterated a Buy rating and $3.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
